ObsEva (NASDAQ:OBSV) Research Coverage Started at StockNews.com

StockNews.com started coverage on shares of ObsEva (NASDAQ:OBSV) in a report published on Thursday. The brokerage issued a hold rating on the stock.

ObsEva Stock Down 100.0 %

ObsEva has a 12 month low of $0.08 and a 12 month high of $2.14. The company’s 50-day simple moving average is $0.01. The firm has a market cap of $7.94 million, a P/E ratio of -0.11 and a beta of 0.68.

ObsEva Company Profile

ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women’s reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet on November 14, 2012 and is headquartered in Geneva, Switzerland.